HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chinese aspirin

This article was originally published in The Tan Sheet

Executive Summary

Antidumping margin of 144% applicable to all but two bulk aspirin exporters in the People's Republic of China, the International Trade Administration says in a final determination published in the Federal Register May 25. ITA assigns weighted-average dumping margins of 42.8% to Shandong Xinhau Pharmaceutical Factory and 4.7% to Jilin Pharmaceutical. The case now goes to the International Trade Commission, which will issue an antidumping order if it determines Chinese bulk aspirin imports are materially injurious, or threaten material injury, to U.S. industry. The investigation was requested by Cranbury, N.J.-based bulk aspirin maker Rhodia (1"The Tan Sheet" June 14, 1999, p. 9)

Related Content

Topics

UsernamePublicRestriction

Register

RS133016

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel